When and how should insulin be initiated in patients with type 2 diabetes mellitus (T2DM)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Initiating Insulin in Type 2 Diabetes Mellitus

Insulin therapy should be initiated in patients with T2DM who are not achieving glycemic goals with lifestyle intervention and oral hypoglycemic agents, ideally within 3 months of recognition of treatment failure. 1

When to Initiate Insulin

Immediate Insulin Initiation Required:

  • Newly diagnosed T2DM with:
    • HbA1c > 9.0% or FPG ≥ 11.1 mmol/L with symptomatic hyperglycemia 1
    • Blood glucose ≥250 mg/dL 1
    • Presence of ketosis or diabetic ketoacidosis
    • Acute illness or surgery
    • Pregnancy
    • Glucose toxicity

Delayed Insulin Initiation (After Oral Agents):

  • Failure to achieve target HbA1c < 7.0% after 3 months of optimized oral hypoglycemic therapy 1
  • Contraindications to oral antidiabetic medications
  • Need for flexible therapy

How to Initiate Insulin

Initial Insulin Regimen Options:

  1. Basal Insulin Approach (Preferred first-line insulin strategy):

    • Start with intermediate-acting human insulin (NPH) or long-acting insulin analogs (glargine, detemir, degludec)
    • Starting dose: 10 units or 0.1-0.2 units/kg once daily 2
    • Administer at bedtime or any consistent time of day 3
    • Continue metformin and consider discontinuing insulin secretagogues 2
    • Titrate dose by 2-4 units every 3-7 days until target fasting glucose is reached
  2. Premixed Insulin Approach:

    • Premixed human insulin or premixed insulin analogs
    • Typically administered 1-3 times daily 1
    • Consider in patients with regular meal patterns or those who need simplified regimens
  3. Short-term Intensive Insulin Therapy:

    • For newly diagnosed patients with HbA1c > 9.0% or FPG ≥ 11.1 mmol/L 1
    • Duration: 2 weeks to 3 months
    • May help reverse glucose toxicity

Insulin Intensification When Needed:

If basal insulin alone doesn't achieve glycemic targets:

  1. Add mealtime (bolus) insulin:

    • Start with one injection of rapid-acting insulin with largest meal
    • Progress to multiple daily injections as needed (basal-bolus regimen)
    • Typically 40-50% of total daily insulin as bolus insulin 4
  2. Switch to premixed insulin 2-3 times daily 1

  3. Consider continuous subcutaneous insulin infusion (CSII) for selected patients 1

Monitoring and Titration

  • Monitor HbA1c every 3 months 1
  • Self-monitoring of blood glucose:
    • Fasting glucose to titrate basal insulin
    • Pre- and post-prandial glucose to titrate mealtime insulin
  • Equip patients with an algorithm for self-titration of insulin doses 2
  • Intensify treatment if glycemic targets are not met

Special Considerations

  • Hypoglycemia risk: Long-acting insulin analogs (particularly degludec) have lower risk of hypoglycemia compared to NPH insulin 5
  • Weight gain: Combining insulin with metformin may result in less weight gain 6
  • Injection technique: Use shortest available needles (4-6mm) and rotate injection sites to prevent lipohypertrophy 6
  • Barriers to initiation: Address fear of hypoglycemia, injection anxiety, and perceived treatment failure 7

Common Pitfalls to Avoid

  1. Delayed insulin initiation: Don't wait too long to start insulin when oral agents fail
  2. Abrupt discontinuation of oral medications: Continue metformin when starting insulin 6
  3. Inadequate dose titration: Failure to adjust insulin doses frequently enough
  4. Ignoring patient education: Patients need thorough education on injection technique, glucose monitoring, and hypoglycemia management
  5. Overlooking lifestyle modifications: Continue to emphasize diet and exercise alongside insulin therapy

By following this structured approach to insulin initiation in T2DM, clinicians can effectively improve glycemic control and reduce the risk of diabetes-related complications while minimizing adverse effects such as hypoglycemia.

References

Guideline

standards of medical care for type 2 diabetes in china 2019.

Diabetes/Metabolism Research and Reviews, 2019

Guideline

(7) approaches to glycemic treatment.

Diabetes Care, 2015

Research

Consensus on "Basal insulin in the management of Type 2 Diabetes: Which, When and How?".

The Journal of the Association of Physicians of India, 2017

Research

EADSG Guidelines: Insulin Therapy in Diabetes.

Diabetes therapy : research, treatment and education of diabetes and related disorders, 2018

Related Questions

When should insulin therapy be initiated in a newly diagnosed patient with diabetes mellitus?
What are the guidelines for deciding whether to increase basal insulin or pre‑prandial (rapid‑acting) insulin in diabetes management?
In a 27‑year‑old woman with type 2 diabetes, weight 86.6 kg, creatinine 0.40 mg/dL, GFR > 90 mL/min, currently taking neutral protamine Hagedorn (NPH) insulin 32 U at 8 am, dexamethasone 20 mg daily, with an insulin‑to‑carbohydrate ratio (ICR) of 1 U per 3 g carbohydrate and an insulin sensitivity factor (ISF) of 25 mg/dL per U, and blood glucose values of 207 mg/dL at 9 am, 229 mg/dL after a 90‑g carbohydrate meal, 373 mg/dL at 5 pm, 340 mg/dL at 9 pm, and 286 mg/dL at 2 am, what should the NPH basal insulin dose, ISF, and ICR be adjusted to?
For a 59-year-old, 123‑kg man with type 2 diabetes (creatinine 0.84 mg/dL, eGFR > 90 mL/min) currently on U‑500 regular insulin (115 U at breakfast, 115 U at lunch, 50 U at dinner) and receiving dexamethasone 10 mg at 16:00 and 6 mg at 14:30, what NPH (intermediate‑acting) insulin dose should be added and how should the U‑500 insulin doses be adjusted?
How should premixed insulin be initiated and titrated in an adult patient with type 2 diabetes?
How is Left Ventricular Ejection Fraction (LVEF) quantification performed in patients who are candidates for a wearable defibrillator like LifeVest?
Is Lasix (furosemide) safe to take in patients with Chronic Obstructive Pulmonary Disease (COPD)?
What alternative antibiotic can be used for a patient with a urinary tract infection who is allergic to amoxicillin (a type of penicillin) and was previously treated with trimethoprim-sulfamethoxazole (TMP-SMX)?
What are the causes of elevated lipase after cholecystectomy?
What is the difference between Continuous Renal Replacement Therapy (CRRT) and Peritoneal Irrigation and Renal Replacement Therapy (PIRRT)?
What is the recommended treatment and dosage for Bumetanide (generic name) in patients with edema?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.